KATRINA ROBERTSON: Open Payments
NPI 1801469028 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 109 payments from 18 companies in 2025. Trend: 2023 $1,049 · 2024 $2,420 · 2025 $2,106
Food & beverage: $1,910Education: $196
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $322 |
| Janssen Biotech, Inc. | 20 | $314 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $274 |
| Regeneron Healthcare Solutions, Inc. | 6 | $216 |
| UCB, Inc. | 7 | $164 |
| LEO Pharma Inc. | 10 | $161 |
| GENZYME CORPORATION | 6 | $120 |
| Lilly USA, LLC | 4 | $75 |
| Organogenesis Inc. | 4 | $71 |
| Galderma Laboratories, L.P. | 3 | $70 |
Products named: DUPIXENT, TREMFYA, RINVOQ, Bimzelx, LEVULAN KERASTICK, ADBRY, EBGLYSS, NEMLUVIO.
Industry payments across AL — which companies pay providers there.
